keyword
https://read.qxmd.com/read/38639549/newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-systematic-review-and-network-meta-analysis-for-the-american-college-of-physicians
#21
REVIEW
Tyler Drake, Adrienne Landsteiner, Lisa Langsetmo, Roderick MacDonald, Maylen Anthony, Caleb Kalinowski, Kristen Ullman, Charles J Billington, Anjum Kaka, Shahnaz Sultan, Timothy J Wilt
BACKGROUND: Newer diabetes medications may have beneficial effects on mortality, cardiovascular outcomes, and renal outcomes. PURPOSE: To evaluate the effectiveness, comparative effectiveness, and harms of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP1) agonists, dipeptidyl peptidase-4 (DPP4) inhibitors, and long-acting insulins as monotherapy or combination therapy in adults with type 2 diabetes mellitus (T2DM). DATA SOURCES: MEDLINE and EMBASE for randomized controlled trials (RCTs) published from 2010 through January 2023...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38638242/assessing-the-effectiveness-and-safety-of-lenvatinib-and-everolimus-in-advanced-renal-cell-carcinoma-insights-from-the-relieve-study-s-analysis-of-heavily-pretreated-patients
#22
JOURNAL ARTICLE
Sebastiano Buti, Alessandro Olivari, Cristina Masini, Davide Bimbatti, Donata Sartori, Paola Ermacora, Carlo Cattrini, Maria Giuseppa Vitale, Ernesto Rossi, Claudia Mucciarini, Mimma Rizzo, Michele Sisani, Matteo Santoni, Giandomenico Roviello, Veronica Mollica, Vincenza Conteduca, Francesco Grillone, Marika Cinausero, Giuseppe Prati, Francesco Atzori, Marco Stellato, Francesco Massari, Melissa Bersanelli
BACKGROUND: The treatment of heavily pretreated patients with metastatic renal cell carcinoma (mRCC) represents an unmet medical need and is still challenging. OBJECTIVES: The primary objective was to assess the effectiveness of the lenvatinib plus everolimus combination and the secondary objective was the toxicity profile of this combination. DESIGN: We conducted a longitudinal retrospective study examining mRCC patients pre-treated with one or more lines of therapy among different cancer centers in Italy...
2024: Therapeutic Advances in Urology
https://read.qxmd.com/read/38636575/chinese-herbal-medicine-for-the-treatment-of-diabetic-nephropathy-from-clinical-evidence-to-potential-mechanisms
#23
REVIEW
Xiao-Xiao Gong, Lin-Hai Cao, Hong-Xia Ni, Zi-Yan Zang, Hui Chang
ETHNOPHARMACOLOGICAL RELEVANCE: Diabetic nephropathy (DN) is a typical chronic microvascular complication of diabetes, characterized by proteinuria and a gradual decline in renal function. At present, there are limited clinical interventions aimed at preventing the progression of DN to end-stage renal disease (ESRD). However, Chinese herbal medicine presents a distinct therapeutic approach that can be effectively combined with conventional Western medicine treatments to safeguard renal function...
April 16, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38634912/health-and-economic-impact-of-dapagliflozin-for-type-2-diabetes-patients-who-had-or-were-at-risk-for-atherosclerotic-cardiovascular-disease-in-the-italian-general-practitioners-setting-a-budget-impact-analysis
#24
JOURNAL ARTICLE
Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Pasquale Palladino, Marco Gnesi, Silvia Mele, Marco D'Amelio, Elena Zanzottera Ferrari, Giampiero Mazzaglia, Lorenzo Giovanni Mantovani
AIM: In 2022, in Italy, general practitioners (GPs) have been allowed to prescribe SGLT2i in Type 2 Diabetes (T2D) under National Health Service (NHS) reimbursement. In the pivotal clinical trial named DECLARE-TIMI 58, dapagliflozin reduced the risk of hospitalization for heart failure, CV death and kidney disease progression compared to placebo in a population of T2D patients. This study evaluated the health and economic impact of dapagliflozin for T2D patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian GPs setting...
April 18, 2024: Acta Diabetologica
https://read.qxmd.com/read/38634653/gliflozins-in-the-treatment-of-non-diabetic-experimental-cardiovascular-diseases
#25
JOURNAL ARTICLE
I Vaněčková, J Zicha
A new class of antidiabetic drugs - gliflozins (inhibitors of sodium glucose cotransporter-2; SGLT-2i) stimulate glucose and sodium excretion, thereby contributing to improved glycemic control, weight loss and blood pressure reduction in diabetic patients. Large clinical trials in patients with type 2 diabetes treated with empagliflozin, canagliflozin or dapagliflozin have demonstrated their excellent efficacy in improving many cardiovascular outcomes, including the reduction of death from cardiovascular diseases, non-fatal myocardial infarction or stroke, and hospitalization for heart failure...
April 18, 2024: Physiological Research
https://read.qxmd.com/read/38634137/animal-models-to-study-cognitive-impairment-of-chronic-kidney-disease
#26
REVIEW
Pedro H Imenez Silva, Marion Pepin, Andreja Figurek, Eugenio Gutiérrez-Jiménez, Mickaël Bobot, Anna Iervolino, Francesco Mattace-Raso, Ewout J Hoorn, Matthew A Bailey, Lucie Hénaut, Rikke Nielsen, Sebastian Frische, Francesco Trepiccione, Gaye Hafez, Hande O Altunkaynak, Nicole Endlich, Robert Unwin, Giovambattista Capasso, Vesna Pesic, Ziad Massy, Carsten A Wagner, Connect Consortium
Mild cognitive impairment (MCI) is common in people with chronic kidney disease (CKD) and its prevalence increases with progressive loss of kidney function. MCI is characterized by a decline in cognitive performance greater than expected for an individual age and education level but with minimal impairment of instrumental activities of daily living. Deterioration can affect one or several cognitive domains (attention, memory, executive functions, language, and perceptual motor or social cognition). Given the increasing prevalence of kidney disease, more and more people with CKD will also develop MCI causing an enormous disease burden for these individuals, their relatives and society...
April 18, 2024: American Journal of Physiology. Renal Physiology
https://read.qxmd.com/read/38633839/a-20-year-follow-up-study-of-identical-twin-sisters-with-immunoglobulin-a-nephropathy
#27
Masahiro Okabe, Nobuo Tsuboi, Hiroyuki Ueda, Erika Hishida, Yoichi Miyazaki, Takashi Yokoo
Immunoglobulin A nephropathy (IgAN) is characterized by diverse clinicopathological phenotypes. Herein we present a follow-up study of previously reported identical twin sisters with IgAN. The older sister exhibited more severe kidney histopathology and proteinuria and a lower birthweight than did her younger sister, and only the older sister experienced two childbirths. These raised concerns regarding her kidney outcomes. However, with timely multidisciplinary treatments, the older sister's kidney function remained preserved after 20 years of IgAN history...
April 2024: Clinical Kidney Journal
https://read.qxmd.com/read/38633584/novel-peptide-dr3pena-as-a-low-toxicity-antirenal-fibrosis-agent-by-suppressing-the-tgf-%C3%AE-1-mir-212-5p-low-density-lipoprotein-receptor-class-a-domain-containing-4-smad-axis
#28
JOURNAL ARTICLE
Bochuan Deng, Jiao Zhang, Xiang Zhang, Dan Wang, Lu Cheng, Ping Su, Tingli Yu, Guangjun Bao, Guofeng Li, Liang Hong, Xiaokang Miao, Wenle Yang, Rui Wang, Junqiu Xie
Renal fibrosis is a complex pathological process that contributes to the development of chronic kidney disease due to various risk factors. Conservative treatment to curb progression without dialysis or renal transplantation is widely applicable, but its effectiveness is limited. Here, the inhibitory effect of the novel peptide DR3penA (DHα-(4-pentenyl)-AlaNPQIR-NH2 ), which was developed by our group, on renal fibrosis was assessed in cells and mice with established fibrosis and fibrosis triggered by transforming growth factor-β1 (TGF-β1), unilateral ureteral obstruction, and repeated low-dose cisplatin...
April 12, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38633468/tinu-a-multisystemic-inflammatory-disorder-case-report-and-literature-review
#29
Juan Montejo-Hernández, Jorge Rico-Fontalvo, Jose Cabrales, Shuchi Anand, María Cristina Martínez-Ávila, Claudia Duran-Merino, Luis Arias-Restrepo, Camilo Andrés Gómez Duran
Background . The syndrome of tubulointerstitial nephritis and uveitis (TINU) is a rare oculorenal condition, mainly seen in children and women. The underlying cause of this disease is unknown. Case Presentation . We report a 24-year-old male without any past medical history, diagnosed with bilateral uveitis and azotemia. Biopsy revealed tubulointerstitial nephritis, consistent with TINU syndrome. Fluorescein angiogram revealed peripheral retinal vasculitis. Discussion . TINU is a rare disorder that needs to be distinguished from sarcoidosis, Sjogren's disease, and tuberculosis...
2024: Case Reports in Nephrology
https://read.qxmd.com/read/38633264/-nlrp2-deletion-ameliorates-kidney-damage-in-a-mouse-model-of-cystinosis
#30
JOURNAL ARTICLE
Marianna Nicoletta Rossi, Valentina Matteo, Francesca Diomedi-Camassei, Ester De Leo, Olivier Devuyst, Mohamed Lamkanfi, Ivan Caiello, Elena Loricchio, Francesco Bellomo, Anna Taranta, Francesco Emma, Fabrizio De Benedetti, Giusi Prencipe
Cystinosis is a rare autosomal recessive disorder caused by mutations in the CTNS gene that encodes cystinosin, a ubiquitous lysosomal cystine/H+ antiporter. The hallmark of the disease is progressive accumulation of cystine and cystine crystals in virtually all tissues. At the kidney level, human cystinosis is characterized by the development of renal Fanconi syndrome and progressive glomerular and interstitial damage leading to end-stage kidney disease in the second or third decade of life. The exact molecular mechanisms involved in the pathogenesis of renal disease in cystinosis are incompletely elucidated...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38632863/stepwise-algorithm-using-computed-tomography-and-magnetic-resonance-imaging-for-differential-diagnosis-of-fat-poor-angiomyolipoma-in-small-renal-masses-a-prospective-validation-study
#31
JOURNAL ARTICLE
Masahiro Toide, Hajime Tanaka, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Koichiro Kimura, Yuma Waseda, Soichiro Yoshida, Ukihide Tateishi, Yasuhisa Fujii
OBJECTIVES: To validate the diagnostic accuracy of a stepwise algorithm to differentiate fat-poor angiomyolipoma (fp-AML) from renal cancer in small renal masses (SRMs). METHODS: We prospectively enrolled 223 patients with solid renal masses <4 cm and no visible fat on unenhanced computed tomography (CT). Patients were assessed using an algorithm that utilized the dynamic CT and MRI findings in a stepwise manner. The diagnostic accuracy of the algorithm was evaluated in patients whose histology was confirmed through surgery or biopsy...
April 17, 2024: International Journal of Urology: Official Journal of the Japanese Urological Association
https://read.qxmd.com/read/38632124/is-mild-dehydration-a-risk-for-progression-of-childhood-chronic-kidney-disease
#32
REVIEW
Amelia K Le Page, Evan C Johnson, Jason H Greenberg
Children with chronic kidney disease (CKD) can have an inherent vulnerability to dehydration. Younger children are unable to freely access water, and CKD aetiology and stage can associate with reduced kidney concentrating capacity, which can also impact risk. This article aims to review the risk factors and consequences of mild dehydration and underhydration in CKD, with a particular focus on evidence for risk of CKD progression. We discuss that assessment of dehydration in the CKD population is more challenging than in the healthy population, thus complicating the definition of adequate hydration and clinical research in this field...
April 18, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38630537/set7-methyltransferase-and-phenotypic-switch-in-diabetic-glomerular-endothelial-cells
#33
JOURNAL ARTICLE
Scott Maxwell, Jun Okabe, Harikrishnan Kaipananickal, Hanah Rodriguez, Ishant Khurana, Keith Al-Hasani, Bryna S M Chow, Eleni Pitsillou, Tom C Karagiannis, Karin Jandeleit-Dahm, Ronald C W Ma, Yu Huang, Juliana C N Chan, Mark E Cooper, Assam El-Osta
BACKGROUND: Hyperglycaemia influences the development of glomerular endothelial cell damage and nowhere is this more evident than in the progression of diabetic kidney disease (DKD). While the Set7 lysine methyltransferase is a known hyperglycaemic sensor, its role in endothelial cell function in the context of DKD remains poorly understood. METHODS: Single-cell transcriptomics was used to investigate Set7 regulation in a mouse model of DKD, followed by validation of findings using pharmacological and shRNA inhibition of Set7...
April 17, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38629677/gut-microbiota-plays-a-significant-role-in-gout
#34
REVIEW
Zhi-Peng Feng, Xiao-Yan Wang, Hong-Yi Xin, Shao-Li Huang, Hong-Yu Huang, Qiang Xin, Xi-He Zhang, Hong-Wu Xin
With the development of social economy, the incidence of gout is increasing, which is closely related to people's increasingly rich diet. Eating a diet high in purine, fat, sugar and low-fibre for a long time further aggravates gout by affecting uric acid metabolism. The renal metabolism mechanism of uric acid has been thoroughly studied. To find a new treatment method for gout, increasing studies have recently been conducted on the mechanism of intestinal excretion, metabolism and absorption of uric acid. The most important research is the relationship between intestinal microbiota and the risk of gout...
April 2024: Journal of Medical Microbiology
https://read.qxmd.com/read/38628858/a-case-report-of-mediastinal-parathyroid-carcinoma-in-a-chronic-kidney-disease-patient-addressing-management-conundrum
#35
Chukwunonso Ezeani, Gift Echefu, Ifeoluwa Stowe, Damodar Kumbala, Shatha Murad
Parathyroid carcinoma is a rare malignancy; and it is rarer to find one located in an ectopic location. Ectopic parathyroid glands are a reported cause of failed primary surgery for hyperparathyroidism. We report here a 73-year-old male who previously had parathyroidectomy for primary hyperparathyroidism but then had recurrence of his symptoms with a diagnosis of a mediastinal parathyroid carcinoma on further evaluation. This presentation of complicated mediastinal parathyroid carcinoma posed significant diagnostic and management challenges due to comorbid stage IV chronic kidney disease (CKD)...
2024: SAGE Open Medical Case Reports
https://read.qxmd.com/read/38628557/impressive-and-prolonged-response-with-lenvatinib-in-a-highly-pretreated-patient-with-metastatic-clear-cell-renal-cancer-a-case-report
#36
Sara Demurtas, Mara Frascaroli, Federico Sottotetti, Alessandro Rametta, Giuseppe Procopio, Laura Deborah Locati
Clear cell renal carcinoma (ccRCC) can occur in young people and could be associated with an aggressive behavior. While for the first-line treatment in metastatic disease, there is an agreement to rely on an immunotherapy (IO)-based combination regimen, no standard second-line regimens exist. Generally, tyrosine kinase inhibitors (TKIs) are employed, even in sequence, although no trials have demonstrated yet the best succession. Herein, we present the case of a 39-year-old male, with a very aggressive ccRCC with somatic VHL mutation and distant metastases at diagnosis...
2024: Journal of Kidney Cancer and VHL
https://read.qxmd.com/read/38628357/case-report-novel-compound-heterozygous-tprkb-variants-cause-galloway-mowat-syndrome
#37
Takuya Hiraide, Taiju Hayashi, Yusuke Ito, Rei Urushibata, Hiroshi Uchida, Ryoichi Kitagata, Hidetoshi Ishigaki, Tsutomu Ogata, Hirotomo Saitsu, Tokiko Fukuda
BACKGROUND: Galloway-Mowat syndrome (GAMOS) is a rare genetic disease characterized by early-onset nephrotic syndrome and microcephaly with central nervous system abnormalities. Pathogenic variants in genes encoding kinase, endopeptidase, and other proteins of small size (KEOPS) complex subunits cause GAMOS. The subunit TPRKB (TP53RK binding protein) has been reported in only two patients with GAMOS with homozygous missense variants. CLINICAL REPORT: Herein, we described a three-year-old male with GAMOS...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38626794/a-lentivirus-vectored-feline-erythropoietin-gene-therapy-strategy-in-tissue-culture-and-rodent-models-for-the-potential-treatment-of-chronic-renal-disease-associated-anemia
#38
JOURNAL ARTICLE
Sarah E Cook, Diego Castillo, Tatiana Wolf, Chadwick Hillman, Katherine Bauer, Sonyia Williams, Brian G Murphy
OBJECTIVE: The aim of this study was to assess the efficacy and safety of a third-generation lentivirus-based vector encoding the feline erythropoietin (EPO) (feEPO) gene in vitro and in rodent models in vivo. This vector incorporates a genetic mechanism to facilitate the termination of the therapeutic effect in the event of supraphysiologic polycythemia, the herpes simplex virus thymidine kinase (HSV-TK) "suicide gene." ANIMALS: CFRK cells and replication-defective lentiviral vectors encoding feEPO were used for in vitro experiments...
April 20, 2024: American Journal of Veterinary Research
https://read.qxmd.com/read/38626745/prognostic-implications-of-circulating-plasma-cell-percentage-in-multiple-myeloma-and-primary-plasma-cell-leukemia-defined-by-new-criteria
#39
JOURNAL ARTICLE
Xianghong Jin, Xianyong Jiang, Hui Li, Kaini Shen, Shuangjiao Liu, Miao Chen, Chen Yang, Bing Han, Junling Zhuang
INTRODUCTION: The definition of primary plasma cell leukemia (pPCL) has been revised from ≥20% to ≥5% circulating plasma cells (CPC). However, the precise prognosis associated with CPC remains controversial. This study aimed to investigate prognostic biomarkers for myeloma patients based on CPC presence. METHODS: A comprehensive analysis was conducted on 309 consecutive patients diagnosed with either multiple myeloma or pPCL, utilizing peripheral blood smears stained with Wright-Giemsa...
April 16, 2024: Acta Haematologica
https://read.qxmd.com/read/38626182/plasma-proteomics-of-diabetic-kidney-disease-among-asians-with-younger-onset-type-2-diabetes
#40
JOURNAL ARTICLE
Resham Lal Gurung, Huili Zheng, Hiromi Wai Ling Koh, M Yiamunaa, Jian-Jun Liu, Sylvia Liu, Clara Chan, Keven Ang, Clara Si Hua Tan, Radoslaw Mikolaj Sobota, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
CONTEXT: Patients with younger onset of type 2 diabetes (YT2D) have increased risk for kidney failure compared to those with late onset. However, the mechanism of diabetic kidney disease (DKD) progression in this high-risk group is poorly understood. OBJECTIVES: To identify novel biomarkers and potential causal proteins associated with DKD progression in patients with YT2D. DESIGN AND PARTICIPANTS: Among YT2D (T2D onset age ≤ 40 years), 144 DKD progressors (cases) were matched for T2D onset age, sex, and ethnicity with 292 non-progressors (controls) and divided into discovery and validation sets...
April 16, 2024: Journal of Clinical Endocrinology and Metabolism
keyword
keyword
101803
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.